BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31525260)

  • 1. The homozygous variant c.245G > A/p.G82D in PNPLA2 is associated with arrhythmogenic cardiomyopathy phenotypic manifestations.
    Rao M; Guo G; Li M; Chen S; Chen K; Chen X; Song J; Hu S
    Clin Genet; 2019 Dec; 96(6):532-540. PubMed ID: 31525260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole exome sequencing with genomic triangulation implicates CDH2-encoded N-cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy.
    Turkowski KL; Tester DJ; Bos JM; Haugaa KH; Ackerman MJ
    Congenit Heart Dis; 2017 Mar; 12(2):226-235. PubMed ID: 28326674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of a primary role for TTN missense variants in arrhythmogenic cardiomyopathy: From a clinical and pathological perspective.
    Chen K; Song J; Wang Z; Rao M; Chen L; Hu S
    Clin Cardiol; 2018 May; 41(5):615-622. PubMed ID: 29750433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous Desmocollin-2 Mutations and Arrhythmogenic Cardiomyopathy.
    Lorenzon A; Pilichou K; Rigato I; Vazza G; De Bortoli M; Calore M; Occhi G; Carturan E; Lazzarini E; Cason M; Mazzotti E; Poloni G; Mostacciuolo ML; Daliento L; Thiene G; Corrado D; Basso C; Bauce B; Rampazzo A
    Am J Cardiol; 2015 Oct; 116(8):1245-51. PubMed ID: 26310507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-Exome Sequencing Identifies Pathogenic Variants in TJP1 Gene Associated With Arrhythmogenic Cardiomyopathy.
    De Bortoli M; Postma AV; Poloni G; Calore M; Minervini G; Mazzotti E; Rigato I; Ebert M; Lorenzon A; Vazza G; Cipriani A; Bariani R; Perazzolo Marra M; Husser D; Thiene G; Daliento L; Corrado D; Basso C; Tosatto SCE; Bauce B; van Tintelen JP; Rampazzo A
    Circ Genom Precis Med; 2018 Oct; 11(10):e002123. PubMed ID: 30354300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel homozygous stop-gain pathogenic variant of PPP1R13L gene leads to arrhythmogenic cardiomyopathy.
    Kalayinia S; Mahdavi M; Houshmand G; Hesami M; Pourirahim M; Maleki M
    BMC Cardiovasc Disord; 2022 Aug; 22(1):359. PubMed ID: 35933355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
    Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
    PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A founder homozygous DSG2 variant in East Asia results in ARVC with full penetrance and heart failure phenotype.
    Chen L; Rao M; Chen X; Chen K; Ren J; Zhang N; Zhao Q; Yu W; Yuan B; Song J
    Int J Cardiol; 2019 Jan; 274():263-270. PubMed ID: 30454721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features.
    Ghidoni A; Elliott PM; Syrris P; Calkins H; James CA; Judge DP; Murray B; Barc J; Probst V; Schott JJ; Song JP; Hauer RNW; Hoorntje ET; van Tintelen JP; Schulze-Bahr E; Hamilton RM; Mittal K; Semsarian C; Behr ER; Ackerman MJ; Basso C; Parati G; Gentilini D; Kotta MC; Mayosi BM; Schwartz PJ; Crotti L
    Circ Genom Precis Med; 2021 Apr; 14(2):e003097. PubMed ID: 33566628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.
    Stadiotti I; Catto V; Casella M; Tondo C; Pompilio G; Sommariva E
    J Cardiovasc Transl Res; 2017 Dec; 10(5-6):446-454. PubMed ID: 28983804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2.
    Qadri S; Anttonen O; Viikilä J; Seppälä EH; Myllykangas S; Alastalo TP; Holmström M; Heliö T; Koskenvuo JW
    BMC Med Genet; 2017 Aug; 18(1):86. PubMed ID: 28818065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.
    Sen-Chowdhry S; Syrris P; Ward D; Asimaki A; Sevdalis E; McKenna WJ
    Circulation; 2007 Apr; 115(13):1710-20. PubMed ID: 17372169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
    Te Rijdt WP; Asimaki A; Jongbloed JDH; Hoorntje ET; Lazzarini E; van der Zwaag PA; de Boer RA; van Tintelen JP; Saffitz JE; van den Berg MP; Suurmeijer AJH
    Cardiovasc Pathol; 2019; 40():2-6. PubMed ID: 30763825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both?
    Bennett RG; Haqqani HM; Berruezo A; Della Bella P; Marchlinski FE; Hsu CJ; Kumar S
    Heart Lung Circ; 2019 Jan; 28(1):164-177. PubMed ID: 30446243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of novel DSP_p.Q986X genetic variation in arrhythmogenic right ventricular cardiomyopathy.
    Campuzano O; Alcalde M; Berne P; Zorio E; Iglesias A; Navarro-Manchón J; Brugada J; Brugada R
    Eur J Med Genet; 2013 Oct; 56(10):541-5. PubMed ID: 23954618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β.
    Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Domínguez F; Román M; Larrasa-Alonso J; Ortiz-Sánchez P; Martínez F; López-Olañeta M; Bonzón-Kulichenko E; Vázquez J; Martí-Gómez C; Santiago DJ; Prados B; Giovinazzo G; Gómez-Gaviro MV; Priori S; Garcia-Pavia P; Lara-Pezzi E
    Circulation; 2019 Oct; 140(14):1188-1204. PubMed ID: 31567019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic analysis of arrhythmogenic cardiomyopathy in the Hutterite population: role of electrocardiogram in identifying high-risk desmocollin-2 carriers.
    Wong JA; Duff HJ; Yuen T; Kolman L; Exner DV; Weeks SG; Gerull B
    J Am Heart Assoc; 2014 Dec; 3(6):e001407. PubMed ID: 25497880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A homozygous DSC2 deletion associated with arrhythmogenic cardiomyopathy is caused by uniparental isodisomy.
    Brodehl A; Weiss J; Debus JD; Stanasiuk C; Klauke B; Deutsch MA; Fox H; Bax J; Ebbinghaus H; Gärtner A; Tiesmeier J; Laser T; Peterschröder A; Gerull B; Gummert J; Paluszkiewicz L; Milting H
    J Mol Cell Cardiol; 2020 Apr; 141():17-29. PubMed ID: 32201174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile in arrhythmogenic cardiomyopathy and a recessive plakophilin-2 gene mutation.
    Ali M; Bhat IA; Hafeez I; Dar MI; Beig JR; Shah ZA; Iqbal K
    Indian Heart J; 2018; 70(3):421-426. PubMed ID: 29961461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockout of SORBS2 Protein Disrupts the Structural Integrity of Intercalated Disc and Manifests Features of Arrhythmogenic Cardiomyopathy.
    Ding Y; Yang J; Chen P; Lu T; Jiao K; Tester DJ; Giudicessi JR; Jiang K; Ackerman MJ; Li Y; Wang DW; Lee HC; Wang DW; Xu X
    J Am Heart Assoc; 2020 Sep; 9(17):e017055. PubMed ID: 32808564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.